Protect Yourself.

Protect Your Family

Check for drug interactions

Adverse Drug Reactions are the 4th leading cause of death in the U.S.

GeneMedRx drug interaction software can help reduce the risk.

Click Here
DNA Today
View Current Issue

Sign up to receive the latest updates on advances in DNA testing.


tamoxifen logo

Tamoxitest for Tamoxifen Resistance


Genelex will be happy to mail information to you or to your healthcare provider on your behalf, simply complete the request form.



Is your physician thinking of prescribing Tamoxifen?

Are you currently taking Tamoxifen?

Are you concerned about drug effectiveness?

If you answered yes to any of these questions, please download this physician information package so you can discuss Tamoxitest tamoxifen resistance testing (Cytochrome P450 2D6 - CYP2D6) with your healthcare provider. For more information on testing benefits, click here.

One cute baby

Susan's Story

I recovered from ER (estrogen receptor) positive breast cancer and was prescribed tamoxifen to prevent the cancer from coming back. I wanted to do everything possible to make sure that my treatment was successful ...

           
+ Click here to read Susan's story

 

Click here to see what Dr. Susan Love, a respected authority on breast cancer, has to say about tamoxifen DNA testing.

Genelex will be happy to mail information to you or to your healthcare provider on your behalf, simply complete the request form.


Tamoxifen is a medication for the treatment of breast cancer or for people at a high risk of developing breast cancer.

Recent research has shown that 7-10% of women with breast cancer may not receive the full medical benefit from taking tamoxifen due to their unique genetic make-up. These women have a version of a gene called Cytochrome P450 2D6, which reduces the effectiveness of tamoxifen and increase their chance of breast cancer recurrence. The evidence is so strong that an FDA panel recently recommended that the label of tamoxifen be changed to say that 2D6 poor metabolizers who take tamoxifen have a higher risk for breast cancer recurrence, and that testing is available.( Click here to download tamoxifen 2D6 testing information for your healthcare provider).

DNA Drug Sensitivity Testing™ can examine your DNA variations in 2D6 and other important drug processing pathways. Your physician can use this information to adjust dosage and select medications that will be the safest and most effective for you. Since more than 20% of all clinically used medications are metabolized by 2D6, knowing your 2D6 status can help you and your doctor with the future selection of medications.

Genetic testing can tell whether tamoxifen is likely to be an effective treatment for you. This test looks at a specific gene, called 2D6, to determine whether your body can fully metabolize tamoxifen to its active form, endoxifen. If tamoxifen is not an effective treatment, your physician may recommend aromatase inhibitors.

Who Should Be Tested

The CYP2D6 test for tamoxifen is considered appropriate for women who are taking or considering taking tamoxifen to prevent the recurrence of breast cancer. It is especially important if the patient is also taking or considering co-administration with SSRIs.

The Testing Process

The process is simple. You can order testing directly if you have a physician prescription or your healthcare provider can request testing for you. We send a cheek swab collection kit with directions by mail. Samples are submitted using the enclosed return mailer and results are provided in ten days or less. Faster testing is available for an additional charge. Call a DNA testing consultant at (800) 523-3080 for details and to order, or request information to you or to your healthcare provider on your behalf, simply complete the request form.

References

Oesterheld, Jessica, M.D. GeneMedRx Drug Metabolism Tables

Werner Schroth; Matthew P. Goetz; Ute Hamann; et al. Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With tamoxifen JAMA. 2009;302(13):1429-1436

Goetz MP et al. The impact of Cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat 2007; 101 (1): 113-21

Borges S et al. Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. Clin Pharmacol Ther 2006;80(1):61-74

Note: Testing requires a prescription from a physician.

Disclaimer: Do not alter the dosage amount or schedule of any drug you are taking without first consulting a qualified healthcare professional.
The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns.
Unless provided information expressly states that is was created by an MD or PharmD or cites another specific source, it was authored by Genelex employees that are not healthcare providers.

By Kristine Ashcraft, B.S. Last Reviewed 8/2/2010

Questions? Call us at 1-800-523-3080
Request a call Live Chat
Pharmacogenetic testing can help guide clinical medication management
Click Here to Learn More>>
---
Testing Services Offered

What our clients say...

"I just wanted to call and tell you that my physician switched my medications based on my test results, and I cannot describe how much better I feel. You have made a believer out of me, my family, and my physician. I hope this testing becomes routine before anyone is placed on long term medication."
- PY, Eirie, CO
Bookmark and Share